Skip to Main Content
DownloadHi-Res Photo

Lynn Tanoue, MD, MBA

Professor of Medicine (Pulmonary); Vice Chair for Clinical Affairs, Internal Medicine; Director, Lung Cancer Screening Program

Contact Information

Lynn Tanoue, MD, MBA

Mailing Address

  • Pulmonary, Critical Care & Sleep Medicine

    PO Box 208057, 300 Cedar Street

    New Haven, CT 06520-8057

    United States

Related Links

Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile

Research Summary

Dr. Tanoue is Director of the Yale Lung Cancer Screening and Nodule Program, and Principle Investigator for the Yale Lung Cancer Biorepository. Her research interests are focused on early detection and risk stratification for lung cancer, and the development of quality metrics for lung cancer evaluation and lung cancer screening.

Specialized Terms: Lung cancer; Thoracic oncology

Coauthors

Research Interests

Lung Neoplasms; Respiration; Thoracic Neoplasms; Pulmonary Medicine

Selected Publications

  • Lung Cancer: Clinical Evaluation and StagingTanoue, LT. “Lung Cancer: Clinical Evaluation and Staging”, in Comprehensive Respiratory Medicine, Ed. SG Spiro SG and G Silvestri, Mosby, London, in press.
  • Pulmonary Toxicity Associated With Chemotherapeutic Agents.Tanoue LT and McArdle J. Pulmonary Toxicity Associated With Chemotherapeutic Agents. In Fishman’s Textbook of Pulmonary Disorders and Diseases, 3rd Edition, A.P.Fishman, Ed., McGraw Hill, Inc., New York, pp 1067-1102.
  • The effect of diuretics on extrarenal potassium tolerance.Tanoue LT, Aronson PS, Bia MJ. The effect of diuretics on extrarenal potassium tolerance. The Yale Journal Of Biology And Medicine 1982, 55: 421-8. PMID: 7183021, PMCID: PMC2596565.
  • Therapy for stage I and stage II non-small cell lung cancer.Tanoue LT, Ponn RB. Therapy for stage I and stage II non-small cell lung cancer. Clinics In Chest Medicine 2002, 23: 173-90. PMID: 11901910, DOI: 10.1016/s0272-5231(03)00067-4.
  • The noninvasive staging of non-small cell lung cancer: the guidelines.Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 2003, 123: 147S-156S. PMID: 12527574, DOI: 10.1378/chest.123.1_suppl.147s.
  • Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-2003. A 43-year-old man with fever and night sweats.Tanoue LT, Mark EJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-2003. A 43-year-old man with fever and night sweats. The New England Journal Of Medicine 2003, 348: 151-61. PMID: 12519926, DOI: 10.1056/NEJMcpc020026.
  • Pulmonary hypertension in the collagen vascular diseases.Tanoue LT. Pulmonary hypertension in the collagen vascular diseases. Seminars In Respiratory And Critical Care Medicine 2003, 24: 287-96. PMID: 16088549, DOI: 10.1055/s-2003-41089.
  • Case study review.Noble PW, Tanoue L, Homer R. Case study review. Chest 2005, 128: 540S-546S. PMID: 16304245, DOI: 10.1378/chest.128.5_suppl_1.540S.
  • Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy.Decker RH, Tanoue LT, Colasanto JM, Detterbeck FC, Wilson LD. Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy. Oncology (Williston Park, N.Y.) 2006, 20: 727-36. PMID: 16841796.
  • Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities.Decker RH, Tanoue LT, Colasanto JM, Detterbeck FC, Wilson LD. Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities. Oncology (Williston Park, N.Y.) 2006, 20: 899-905; discussion 905-8, 913. PMID: 16922260.
  • High rate of negative results of tuberculin and QuantiFERON tests among individuals with a history of positive skin test results.Friedman LN, Nash ER, Bryant J, Henry S, Shi J, D'Amato J, Khaled GH, Russi MB, O'Connor PG, Edberg SC, Pisani MA, Cain HC, Tanoue L, Weissman DN. High rate of negative results of tuberculin and QuantiFERON tests among individuals with a history of positive skin test results. Infection Control And Hospital Epidemiology 2006, 27: 436-41. PMID: 16671022, DOI: 10.1086/503690.
  • Treatment of lung cancer in older patients.Tanoue LT, Gettinger S. Treatment of lung cancer in older patients. Clinics In Chest Medicine 2007, 28: 735-49, vi. PMID: 17967291, DOI: 10.1016/j.ccm.2007.08.003.
  • Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007, 132: 178S-201S. PMID: 17873168, DOI: 10.1378/chest.07-1360.
  • Massive intravascular hemolysis and a rapidly fatal outcome.Kapoor JR, Monteiro B, Tanoue L, Siegel MD. Massive intravascular hemolysis and a rapidly fatal outcome. Chest 2007, 132: 2016-9. PMID: 18079238, DOI: 10.1378/chest.07-0853.
  • Lung cancer: evolving concepts.Silvestri GA, Tanoue LT. Lung cancer: evolving concepts. Seminars In Respiratory And Critical Care Medicine 2008, 29: 221-2. PMID: 18506659, DOI: 10.1055/s-2008-1076741.
  • Staging of non-small cell lung cancer.Tanoue LT. Staging of non-small cell lung cancer. Seminars In Respiratory And Critical Care Medicine 2008, 29: 248-60. PMID: 18506663, DOI: 10.1055/s-2008-1076745.
  • Pulmonary Problems in Lung Cancer SurvivorsMiller K and Tanoue LT. Pulmonary Problems in Lung Cancer Survivors. In Medical and Psychosocial Care of the Cancer Survivor. KD Miller, Ed. Jones and Bartlett Publishers, Sudbury, MA. 2009, pp 299-312.
  • Lung Cancer: Epidemiology and Carcinogenesis.Dela Cruz C, Tanoue LT, and Matthay RT. Lung Cancer: Epidemiology and Carcinogenesis. In General Thoracic Surgery, Seventh Edition; Shields TW, Locicero J III, Reed CD, and Feins RH, and Rusch VW, Eds. Lippincott, Williams & Wilkins, Philadelphia. 2009, pp 1281-1298.
  • Anatomy, biology and concepts, pertaining to lung cancer stage classification.Detterbeck FC, Tanoue LT, Boffa DJ. Anatomy, biology and concepts, pertaining to lung cancer stage classification. Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer 2009, 4: 437-43. PMID: 19333070, DOI: 10.1097/JTO.0b013e31819852ed.
  • New TNM classification for non-small-cell lung cancer.Tanoue LT, Detterbeck FC. New TNM classification for non-small-cell lung cancer. Expert Review Of Anticancer Therapy 2009, 9: 413-23. PMID: 19374596, DOI: 10.1586/era.09.11.
  • High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.Anagnostou VK, Bepler G, Syrigos KN, Tanoue L, Gettinger S, Homer RJ, Boffa D, Detterbeck F, Rimm DL. High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2009, 15: 4157-64. PMID: 19509151, DOI: 10.1158/1078-0432.CCR-09-0099.
  • The new lung cancer staging system.Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009, 136: 260-271. PMID: 19584208, DOI: 10.1378/chest.08-0978.
  • Lung CancerTanoue. LT. Lung Cancer. In Breathing in America: Diseases, Progress, and Hope. Ed. De Schraufnagel. American Thoracic Society 2010, pp. 109-120.
  • [Anatomy, biology and concepts, pertaining to lung cancer stage classification].Detterbeck FC, Tanoue LT, Boffa DJ. [Anatomy, biology and concepts, pertaining to lung cancer stage classification]. Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer 2010, 13: 1-8. PMID: 20672696, PMCID: PMC6136057, DOI: 10.3779/j.issn.1009-3419.2010.01.01.
  • High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.Anagnostou VK, Lowery FJ, Zolota V, Tzelepi V, Gopinath A, Liceaga C, Panagopoulos N, Frangia K, Tanoue L, Boffa D, Gettinger S, Detterbeck F, Homer RJ, Dougenis D, Rimm DL, Syrigos KN. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology. BMC Cancer 2010, 10: 186. PMID: 20459695, PMCID: PMC2875218, DOI: 10.1186/1471-2407-10-186.
  • Details and difficulties regarding the new lung cancer staging system.Detterbeck FC, Boffa DJ, Tanoue LT, Wilson LD. Details and difficulties regarding the new lung cancer staging system. Chest 2010, 137: 1172-80. PMID: 20442118, DOI: 10.1378/chest.09-2626.
  • Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer?Boffa DJ, Detterbeck FC, Smith EJ, Rami-Porta R, Crowley J, Zelterman D, Tanoue L, Kim AW, Goldstraw P. Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer? Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer 2010, 5: 1779-83. PMID: 20975377, DOI: 10.1097/JTO.0b013e3181ee80c7.
  • Lung CancerTanoue, LT. Lung Cancer. In Yearbook of Pulmonary Medicine 2011. JA Barker, Ed. Elsevier Mosby, Philadelphia. 2011, pp 61-106.
  • Lung Cancer in Older Patients.Gettinger S. and Tanoue, LT. Lung Cancer in Older Patients. In Aging and Lung Diseases, M. Pisani Ed, Springer, New York, 2011, pp 89-110.
  • Lung cancer: epidemiology, etiology, and prevention.Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clinics In Chest Medicine 2011, 32: 605-44. PMID: 22054876, PMCID: PMC3864624, DOI: 10.1016/j.ccm.2011.09.001.
  • Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay.Anagnostou VK, Dimou AT, Botsis T, Killiam EJ, Gustavson MD, Homer RJ, Boffa D, Zolota V, Dougenis D, Tanoue L, Gettinger SN, Detterbeck FC, Syrigos KN, Bepler G, Rimm DL. Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay. Cancer 2012, 118: 1607-18. PMID: 22009766, DOI: 10.1002/cncr.26450.
  • Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer.Vest MT, Tanoue L, Soulos PR, Kim AW, Detterbeck F, Morgensztern D, Gross CP. Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer. Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer 2012, 7: 188-95. PMID: 22134069, PMCID: PMC3253367, DOI: 10.1097/JTO.0b013e318236ecbb.
  • Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, Harris LJ, Detterbeck FC. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143: e211S-e250S. PMID: 23649440, DOI: 10.1378/chest.12-2355.
  • Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Ost DE, Yeung SC, Tanoue LT, Gould MK. Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143: e121S-e141S. PMID: 23649435, PMCID: PMC4694609, DOI: 10.1378/chest.12-2352.
  • The stage classification of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Detterbeck FC, Postmus PE, Tanoue LT. The stage classification of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143: e191S-e210S. PMID: 23649438, DOI: 10.1378/chest.12-2354.
  • Use of new treatment modalities for non-small cell lung cancer care in the Medicare population.Vest MT, Herrin J, Soulos PR, Decker RH, Tanoue L, Michaud G, Kim AW, Detterbeck F, Morgensztern D, Gross CP. Use of new treatment modalities for non-small cell lung cancer care in the Medicare population. Chest 2013, 143: 429-435. PMID: 23187634, PMCID: PMC3566996, DOI: 10.1378/chest.12-1149.
  • National comprehensive cancer network.Detterbeck F, Tanoue L, Reid A. National comprehensive cancer network. Journal Of The National Comprehensive Cancer Network : JNCCN 2013, 11: 365-6. PMID: 23584338, DOI: 10.6004/jnccn.2013.0050.
  • The Role of the Advanced Practitioner in a Comprehensive Lung Cancer Screening and Pulmonary Nodule Program.Reid AE, Tanoue L, Detterbeck F, Michaud GC, McCorkle R. The Role of the Advanced Practitioner in a Comprehensive Lung Cancer Screening and Pulmonary Nodule Program. Journal Of The Advanced Practitioner In Oncology 2014, 5: 440-6. PMID: 26328217, PMCID: PMC4530114, DOI: 10.6004/jadpro.2014.5.6.4.
  • Lung cancer screening.Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung cancer screening. American Journal Of Respiratory And Critical Care Medicine 2015, 191: 19-33. PMID: 25369325, DOI: 10.1164/rccm.201410-1777CI.
  • Reply: Lung Cancer Screening: The Balance between Harm and Benefit.Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Reply: Lung Cancer Screening: The Balance between Harm and Benefit. American Journal Of Respiratory And Critical Care Medicine 2015, 191: 1209-10. PMID: 25978579, DOI: 10.1164/rccm.201503-0526LE.
  • Effects of one-hour training course and spirometry on the ability of physicians to diagnose and treat chronic obstructive pulmonary disease.Cai S, Qin L, Tanoue L, Hu A, Jia X, Luo H, Chen Y, Chen P, Peng H. Effects of one-hour training course and spirometry on the ability of physicians to diagnose and treat chronic obstructive pulmonary disease. PloS One 2015, 10: e0117348. PMID: 25706774, PMCID: PMC4338104, DOI: 10.1371/journal.pone.0117348.
  • Lung cancer screening.Tanoue LT. Lung cancer screening. Current Opinion In Pulmonary Medicine 2016, 22: 327-35. PMID: 27159896, DOI: 10.1097/MCP.0000000000000287.
  • The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.Detterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg DA, Travis WD, Mazzone PJ, Marom EM, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R. The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer 2016, 11: 651-665. PMID: 26944304, DOI: 10.1016/j.jtho.2016.01.025.
  • The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.Detterbeck FC, Bolejack V, Arenberg DA, Crowley J, Donington JS, Franklin WA, Girard N, Marom EM, Mazzone PJ, Nicholson AG, Rusch VW, Tanoue LT, Travis WD, Asamura H, Rami-Porta R. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer 2016, 11: 681-692. PMID: 26940530, DOI: 10.1016/j.jtho.2015.12.114.
  • The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification.Detterbeck FC, Marom EM, Arenberg DA, Franklin WA, Nicholson AG, Travis WD, Girard N, Mazzone PJ, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification. Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer 2016, 11: 666-680. PMID: 26940527, DOI: 10.1016/j.jtho.2015.12.113.
  • The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification.Detterbeck FC, Nicholson AG, Franklin WA, Marom EM, Travis WD, Girard N, Arenberg DA, Bolejack V, Donington JS, Mazzone PJ, Tanoue LT, Rusch VW, Crowley J, Asamura H, Rami-Porta R. The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification. Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer 2016, 11: 639-650. PMID: 26940528, DOI: 10.1016/j.jtho.2016.01.024.
  • Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.Erb CT, Su KW, Soulos PR, Tanoue LT, Gross CP. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population. Lung Cancer (Amsterdam, Netherlands) 2016, 99: 200-7. PMID: 27565940, PMCID: PMC5003420, DOI: 10.1016/j.lungcan.2016.07.017.
  • The Eighth Edition Lung Cancer Stage Classification.Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The Eighth Edition Lung Cancer Stage Classification. Chest 2017, 151: 193-203. PMID: 27780786, DOI: 10.1016/j.chest.2016.10.010.
  • Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement.Rivera MP, Tanner NT, Silvestri GA, Detterbeck FC, Tammemägi MC, Young RP, Slatore CG, Caverly TJ, Boyd CM, Braithwaite D, Fathi JT, Gould MK, Iaccarino JM, Malkoski SP, Mazzone PJ, Tanoue LT, Schoenborn NL, Zulueta JJ, Wiener RS. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. American Journal Of Respiratory And Critical Care Medicine 2018, 198: e3-e13. PMID: 30004250, DOI: 10.1164/rccm.201805-0986ST.
  • Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose.Ye Q, Wu J, Lu Y, Naganawa M, Gallezot JD, Ma T, Liu Y, Tanoue L, Detterbeck F, Blasberg J, Chen MK, Casey M, Carson RE, Liu C. Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose. Physics In Medicine And Biology 2018, 63: 175015. PMID: 30095083, PMCID: PMC6158045, DOI: 10.1088/1361-6560/aad97f.
  • Addressing Gender Inequality in Our Disciplines: Report from the Association of Pulmonary, Critical Care, and Sleep Division Chiefs.Thomson CC, Riekert KA, Bates CK, Jena AB, Borok Z, McCallister JW, Schnapp LM, Lama VN, Kraft M, Davis SD, Finn P, Carson SS, Beck JM, Powell CA, Tanoue LT, Kaminski N, Dixon AE. Addressing Gender Inequality in Our Disciplines: Report from the Association of Pulmonary, Critical Care, and Sleep Division Chiefs. Annals Of The American Thoracic Society 2018, 15: 1382-1390. PMID: 30153425, DOI: 10.1513/AnnalsATS.201804-252AR.
  • Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done.Burks AC, Gould MK, Silvestri G, Yarmus LB, Sears CR, Arenberg DA, Gonzalez AV, Slatore CG, Tanner NT, Vachani A, Nana-Sinkam P, Fuster MM, Wahidi MM, Tanoue LT, Rivera MP. Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. Annals Of The American Thoracic Society 2019, 16: 1360-1362. PMID: 31437410, DOI: 10.1513/AnnalsATS.201905-389PS.
  • Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest 2020, 158: 406-415. PMID: 32335067, PMCID: PMC7177089, DOI: 10.1016/j.chest.2020.04.020.
  • Lung Cancer Staging.Tanoue LT. Lung Cancer Staging. Clinics In Chest Medicine 2020, 41: 161-174. PMID: 32402353, DOI: 10.1016/j.ccm.2020.02.006.
  • Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Journal Of The American College Of Radiology : JACR 2020, 17: 845-854. PMID: 32485147, PMCID: PMC7177099, DOI: 10.1016/j.jacr.2020.04.024.
  • A 62-Year-Old Woman With Lung Cancer, Ulcerating Rash, and Rapidly Progressive Hypoxemia.Kunitomo Y, Young G, Datta R, Korn LL, Tanoue L, Gautam S. A 62-Year-Old Woman With Lung Cancer, Ulcerating Rash, and Rapidly Progressive Hypoxemia. Chest 2020, 158: e191-e196. PMID: 33036118, PMCID: PMC7533682, DOI: 10.1016/j.chest.2020.06.020.
  • Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Radiology. Imaging Cancer 2020, 2: e204013. PMID: 33778716, PMCID: PMC7233408, DOI: 10.1148/rycan.2020204013.
  • "Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study".Bade BC, Gan G, Li F, Lu L, Tanoue L, Silvestri GA, Irwin ML. "Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study". BMC Cancer 2021, 21: 352. PMID: 33794808, PMCID: PMC8015735, DOI: 10.1186/s12885-021-08084-0.
  • Women and Lung Cancer.Tanoue LT. Women and Lung Cancer. Clinics In Chest Medicine 2021, 42: 467-482. PMID: 34353452, DOI: 10.1016/j.ccm.2021.04.007.
  • Racial Differences in Adherence to Lung Cancer Screening Follow-up: A Systematic Review and Meta-analysis.Kunitomo Y, Bade B, Gunderson CG, Akgün KM, Brackett A, Cain H, Tanoue L, Bastian LA. Racial Differences in Adherence to Lung Cancer Screening Follow-up: A Systematic Review and Meta-analysis. Chest 2022, 161: 266-275. PMID: 34390706, DOI: 10.1016/j.chest.2021.07.2172.
  • Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation.Salloum E, Tanoue LT, Wackers FJ, Zelterman D, Hu GL, Cooper DL. Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation. Cancer Investigation 1999, 17: 171-80. PMID: 10099655, DOI: 10.3109/07357909909021418.
  • Lung transplantation.Tanoue LT. Lung transplantation. Lung 1992, 170: 187-200. PMID: 1522739, DOI: 10.1007/BF00174116.
  • Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjögren's syndrome, and relapsing polychondritis.Tanoue LT. Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjögren's syndrome, and relapsing polychondritis. Journal Of Thoracic Imaging 1992, 7: 62-77. PMID: 1578527.
  • Use of neodymium yttrium aluminum garnet laser in long-term palliation of airway obstruction.Quin JA, Letsou GV, Tanoue LT, Matthay RA, Higgins RS, Baldwin JC. Use of neodymium yttrium aluminum garnet laser in long-term palliation of airway obstruction. Connecticut Medicine 1995, 59: 407-12. PMID: 7545564.
  • Vitamin A chemoprevention of lung cancer. A short-term biomarker study.Redlich CA, Van Bennekum AM, Wirth JA, Blaner WS, Carter D, Tanoue LT, Holm CT, Cullen MR. Vitamin A chemoprevention of lung cancer. A short-term biomarker study. Advances In Experimental Medicine And Biology 1995, 375: 17-29. PMID: 7645426, DOI: 10.1007/978-1-4899-0949-7_2.
  • Pulmonary manifestations of rheumatoid arthritis.Tanoue LT. Pulmonary manifestations of rheumatoid arthritis. Clinics In Chest Medicine 1998, 19: 667-85, viii. PMID: 9917959, DOI: 10.1016/s0272-5231(05)70109-x.
  • Cigarette smoking and women's respiratory health.Tanoue LT. Cigarette smoking and women's respiratory health. Clinics In Chest Medicine 2000, 21: 47-65, viii. PMID: 10763089, DOI: 10.1016/s0272-5231(05)70007-1.
  • Preoperative evaluation of the high-risk surgical patient for lung cancer resection.Tanoue LT. Preoperative evaluation of the high-risk surgical patient for lung cancer resection. Seminars In Respiratory And Critical Care Medicine 2000, 21: 421-32. PMID: 16088753, DOI: 10.1055/s-2000-9404.
  • Standardizing the Reporting of Incidental, Non-Lung Cancer (Category S) Findings Identified on Lung Cancer Screening Low-Dose CT Imaging.Tanoue LT, Sather P, Cortopassi I, Dicks D, Curtis A, Michaud G, Bader A, Gange C, Detterbeck F, Killam J. Standardizing the Reporting of Incidental, Non-Lung Cancer (Category S) Findings Identified on Lung Cancer Screening Low-Dose CT Imaging. Chest 2022 PMID: 35032477, DOI: 10.1016/j.chest.2021.12.662.
  • RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition.Hunihan L, Zhao D, Lazowski H, Li M, Qian Y, Abriola L, Surovtseva YV, Muthusamy V, Tanoue LT, Gould Rothberg BE, Schalper KA, Herbst RS, Wilson FH. RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2022 PMID: 35247929, DOI: 10.1158/1078-0432.CCR-21-4291.

Clinical Trials

ConditionsStudy Title
Diseases of the Respiratory SystemPeripheral Blood Profiling to Screen Patients for Lung Cancer or Lung Cancer Recurrence
Edit Profile